Leading Cannabis Company Takes Legal Action Against Former Competitor

Mary's Medicinals Logo

Colorado-based Mary’s Medicinals, which has established itself as a leading provider of topical cannabis products and has extended its brand into other states with licensing agreements, has filed suit against Joshua Meacham, who was formerly the owner of RX Green Cannabis.  The company detailed its allegations in a press release, suggesting that Meacham, who sold his ownership stake for $15,000 last year, has engaged in “libel, slander, civil conspiracy, intentional interference with prospective business relations, and intentional interference with contractual relations.”

Mary’s Medicinals detailed several allegations, suggesting Meacham submitted fraudulent reports to the Marijuana Enforcement Division and Colorado Department of Public Health & Environment and that RX Green misappropriated its content.  The company engaged Security Grade Protective Services to help in its investigation.

Meacham faces other legal challenges, as he was  arrested and charged with selling fake elk-hunting permits in September.  His application to open RX Green in Aspen had been held up due to his failure to disclose his arrest record in Arizona, though the business did receive its license in early 2015. RX Green was also hit with a warning about its products by the Denver Department of Environmental Health, which resulted in the removal of its products from dispensaries in September.

Sadly, the evidence seems to suggest that RX Green’s entire business strategy revolved around imitation, scare tactics and trying to trash competitors at the expense of patients and the entire medical cannabis movement.

nicole smith marys medicinals photo
Nicole Smith, CEO of Mary’s Medicinals
Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter